Medicare Enrolled

Dr. David Makover, MD

Rheumatology · Boca Raton, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2900 N MILITARY TRL, Boca Raton, FL 33431
5613670078
Registered in NPPES since 2006
NPI: 1407968787 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Makover from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makover? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Makover

Dr. David Makover is a rheumatology specialist in Boca Raton, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Makover performed 166,138 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Makover received a total of $5,624 from 34 pharmaceutical and/or device companies across 267 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Makover is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 12% volume in FL $5,624 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 56294 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
166,138
Medicare services
Top 12% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
72,000 $4 $11
Romosozumab injection (Evenity) for osteoporosis 38,010 $8 $22
Denosumab injection (Prolia/Xgeva) 25,200 $18 $43
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
16,800 $17 $39
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
9,300 $34 $85
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,260 $26 $71
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
1,063 $59 $189
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
302 $105 $344
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
238 $68 $184
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
203 $8 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
195 $98 $270
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
160 $6 $18
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
103 $108 $415
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
81 $5 $12
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
75 $23 $110
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
42 $54 $207
New patient office visit, complex (60-74 min) 38 $174 $521
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
34 $48 $270
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
34 $145 $364
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.3% high complexity
82.2% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,624
Total received (2018-2024)
Avg $803/year across 7 years
Bottom 45% in FL for rheumatology
34
Companies
267
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,091
2023
$1,306
2022
$1,080
2021
$713
2020
$378
2019
$363
2018
$693

Payments by company (2024)

ANI Pharmaceuticals, Inc.
$180
ABBVIE INC.
$126
Mallinckrodt Hospital Products Inc.
$114
UCB, Inc.
$95
E.R. Squibb & Sons, L.L.C.
$83
AstraZeneca Pharmaceuticals LP
$82
Fresenius Kabi USA, LLC
$61
Janssen Biotech, Inc.
$55
PFIZER INC.
$50
DePuy Synthes Sales Inc.
$48
Kiniksa Pharmaceuticals International, plc
$41
Organon Llc
$29
Alexion Pharmaceuticals, Inc.
$29
GlaxoSmithKline, LLC.
$23
Alvogen Inc
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Amgen Inc.
$18
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$689
Amgen Inc.
$598
UCB, Inc.
$555
PFIZER INC.
$472
Janssen Biotech, Inc.
$368
Lilly USA, LLC
$332
E.R. Squibb & Sons, L.L.C.
$319
ANI Pharmaceuticals, Inc.
$257
Mallinckrodt Hospital Products Inc.
$219
GlaxoSmithKline, LLC.
$211
AbbVie Inc.
$188
Genentech USA, Inc.
$175
Horizon Therapeutics plc
$163
AstraZeneca Pharmaceuticals LP
$149
DePuy Synthes Sales Inc.
$123
Organon LLC
$86
Fresenius Kabi USA, LLC
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
AbbVie, Inc.
$63
Radius Health, Inc.
$62
Mallinckrodt LLC
$60
GENZYME CORPORATION
$52
Mallinckrodt Enterprises LLC
$43
SANOFI-AVENTIS U.S. LLC
$43
Alvogen Inc
$42
Kiniksa Pharmaceuticals International, plc
$41
Takeda Pharmaceuticals U.S.A., Inc.
$30
Organon Llc
$29
Alexion Pharmaceuticals, Inc.
$29
Mylan Institutional Inc.
$21
Novartis Pharmaceuticals Corporation
$19
MEDEXUS PHARMA, INC.
$17
Ironwood Pharmaceuticals, Inc
$13
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUZALLO · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYQVIA · Hulio · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TERIPARATIDE · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Boca Raton?
Compare rheumatologists in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
67
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BOCA RATON REGIONAL HOSPITAL
1.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Makover is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Makover experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Makover performed 72,000 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Makover receive payments from pharmaceutical companies?
Yes. Dr. Makover received a total of $5,624 from 34 companies across 267 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makover's costs compare to other rheumatologists in Boca Raton?
Dr. Makover's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makover) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →